» Articles » PMID: 26838317

More Than Tiny Sacks: Stem Cell Exosomes As Cell-Free Modality for Cardiac Repair

Overview
Journal Circ Res
Date 2016 Feb 4
PMID 26838317
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell therapy provides immense hope for regenerating the pathological heart, yet has been marred by issues surrounding the effectiveness, unclear mechanisms, and survival of the donated cell population in the ischemic myocardial milieu. Poor survival and engraftment coupled to inadequate cardiac commitment of the adoptively transferred stem cells compromises the improvement in cardiac function. Various alternative approaches to enhance the efficacy of stem cell therapies and to overcome issues with cell therapy have been used with varied success. Cell-free components, such as exosomes enriched in proteins, messenger RNAs, and miRs characteristic of parental stem cells, represent a potential approach for treating cardiovascular diseases. Recently, exosomes from different kinds of stem cells have been effectively used to promote cardiac function in the pathological heart. The aim of this review is to summarize current research efforts on stem cell exosomes, including their potential benefits and limitations to develop a potentially viable therapy for cardiovascular problems.

Citing Articles

Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration.

Chen B, Zhao Y, Wu J, Zhu Z, Yang X, Fang R Biomedicines. 2025; 13(2).

PMID: 40002766 PMC: 11853446. DOI: 10.3390/biomedicines13020353.


Osteoporosis under psychological stress: mechanisms and therapeutics.

Xu H, Liu J, Zhou Z, Zheng C, Sui B, Yuan Y Life Med. 2025; 3(1):lnae009.

PMID: 39872391 PMC: 11749647. DOI: 10.1093/lifemedi/lnae009.


Functional large-conductance calcium and voltage-gated potassium channels in extracellular vesicles act as gatekeepers of structural and functional integrity.

Sanghvi S, Sridharan D, Evans P, Dougherty J, Szteyn K, Gabrilovich D Nat Commun. 2025; 16(1):42.

PMID: 39747826 PMC: 11697022. DOI: 10.1038/s41467-024-55379-4.


Advancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency.

Baranwal G, Mukhtar H, Kane J, Lemieux A, Misra S Int J Mol Sci. 2024; 25(23).

PMID: 39684430 PMC: 11641758. DOI: 10.3390/ijms252312719.


Can miRNAs in MSCs-EVs Offer a Potential Treatment for Hypoxic-ischemic Encephalopathy?.

Al-Ward H, Chen W, Gao W, Zhang C, Yang X, Xiong Y Stem Cell Rev Rep. 2024; 21(1):236-253.

PMID: 39503828 DOI: 10.1007/s12015-024-10803-6.


References
1.
Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355(12):1210-21. DOI: 10.1056/NEJMoa060186. View

2.
Dennis J, Merriam A, Awadallah A, Yoo J, Johnstone B, Caplan A . A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res. 1999; 14(5):700-9. DOI: 10.1359/jbmr.1999.14.5.700. View

3.
Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, Biancone L . Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol. 2012; 25(1):75-85. DOI: 10.1177/039463201202500110. View

4.
Frank F, Sonenberg N, Nagar B . Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2. Nature. 2010; 465(7299):818-22. DOI: 10.1038/nature09039. View

5.
Al Attar N, Carrion C, Ghostine S, Garcin I, Vilquin J, Hagege A . Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res. 2003; 58(1):142-8. DOI: 10.1016/s0008-6363(02)00790-3. View